Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

51.9K
Overview
51.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency (HORNbILL): study protocol for a multicentre randomised placebo-controlled trial.

BMJ open·2026
Same author

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Critical care medicine·2026
Same author

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Rethinking fairness in unsupervised healthcare AI: A methodological scoping review.

Journal of biomedical informatics·2026
Same author

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.

Journal of neuromuscular diseases·2026
Same author

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Response letter to "Venovenous extracorporeal membrane oxygenation initiation and reduction in vasopressor requirements".

Annals of intensive care·2026
Same journal

Impact of Respiratory Effort Parameters on Clinical Outcomes in Respiratory Failure Patients (Effort-I): A Prospective Observational Study.

Annals of intensive care·2026
Same journal

Human Development Index and outcomes in older critically ill patients: A European multicentre study.

Annals of intensive care·2026
Same journal

Impact of gender on how intensive care medicine residents experience their medical studies and training and perceive their specialty: a national survey.

Annals of intensive care·2026
Same journal

Diagnosis and management of Children with Post-Intensive Care Syndrome in Paediatrics: Clinical Practice Guidelines by the French National Authority for Health (HAS).

Annals of intensive care·2026
Same journal

Is arterial hypotension the real enemy in septic shock or is it just cosmetic?

Annals of intensive care·2026
See all related articles

Related Experiment Video

Updated: Dec 31, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

435

Understanding brain dysfunction in sepsis.

Romain Sonneville1, Franck Verdonk, Camille Rauturier

  • 1Histopathologie Humaine et Modèles Animaux, Département Infection et Epidémiologie, Institut Pasteur, Paris, France. tarek.sharshar@rpc.aphp.fr.

Annals of Intensive Care
|May 31, 2013
PubMed
Summary
This summary is machine-generated.

Sepsis frequently causes acute brain dysfunction, increasing patient mortality. Understanding its complex causes, like inflammation and impaired brain blood flow, is key to improving outcomes.

More Related Videos

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.4K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.5K

Related Experiment Videos

Last Updated: Dec 31, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

435
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.4K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.5K

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Pathophysiology

Background:

  • Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
  • Acute brain dysfunction is a common and serious complication of sepsis, significantly contributing to mortality.
  • The underlying pathophysiology involves complex inflammatory and non-inflammatory mechanisms affecting the brain.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, and management of sepsis-induced brain dysfunction.
  • To highlight the role of neuroimaging, particularly MRI, in diagnosing and understanding brain alterations in sepsis.
  • To identify potential therapeutic targets for mitigating neurological damage in sepsis.

Main Methods:

  • Literature review of studies on sepsis and brain dysfunction.
  • Analysis of diagnostic approaches including neurological examination, EEG, and neuroimaging (MRI).
  • Discussion of current management strategies and emerging therapeutic targets.

Main Results:

  • Sepsis-induced brain dysfunction involves microglial activation, impaired cerebral perfusion, blood-brain barrier issues, and altered neurotransmission.
  • MRI studies reveal potential acute cerebrovascular lesions and white matter abnormalities in septic shock.
  • Management focuses on sepsis control, preventing aggravating factors, and exploring neuroprotective strategies.

Conclusions:

  • Sepsis-induced brain dysfunction is a complex condition requiring multifaceted management.
  • Targeting microglial activation, blood-brain barrier integrity, and oxidative stress shows therapeutic promise.
  • Further research is needed to reduce the duration of brain dysfunction and improve long-term outcomes in sepsis survivors.